Sign Up to like & get
recommendations!
0
Published in 2019 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-019-04389-2
Abstract: PurposePeptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) is an effective therapy for metastatic neuroendocrine neoplasia (NEN), but therapy-related myeloid neoplasms (t-MN) remain of concern. The study reviewed the clinicopathological features and outcomes of patients who developed t-MN.MethodsRetrospective…
read more here.
Keywords:
therapy;
prrt prcrt;
radionuclide chemoradionuclide;
receptor radionuclide ... See more keywords